Cardio Diagnostics Holdings, Inc. announced a continued expansion of its reach by partnering with 10 new healthcare practices across five states and Puerto Rico. This marks the company's first partner outside the continental U.S., extending its AI-driven cardiovascular testing to the Caribbean.
The new adopters include a wide range of care models, such as concierge, direct primary care, functional, and integrative medicine practices. This diversity demonstrates a growing appetite for proactive, personalized cardiovascular care solutions.
These partnerships are crucial for integrating Cardio Diagnostics’ Epi+Gen CHD and PrecisionCHD tests into everyday practice. This expansion supports the shift toward preventive cardiology by equipping clinicians with tools for earlier and more accurate heart disease detection.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.